This inventor holds 1 USPTO granted patent. Top assignees: Behringwerke Aktiengesellschaft, Dana-Farber-Cancer Institute Inc.. Active years: 1995.
Company Filing History:
1 out of 340 
1 out of 1,265 
Years Active: 1995
Title: Bernard Fleckenstein: Innovator in Cell Line Development
Introduction
Bernard Fleckenstein is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of vectors for cell line establishment. His work has implications for both research and therapeutic applications.
Latest Patents
Fleckenstein holds a patent for the H. saimiri-HTLV-X region vector. This innovative vector can be utilized to establish continuous cell lines of difficult-to-grow cells, such as human T-cells. Additionally, it can be employed to obtain specific cell products and in methods for screening new compounds. His patent represents a valuable advancement in cell biology and biotechnology.
Career Highlights
Throughout his career, Fleckenstein has worked with prestigious organizations, including the Dana-Farber Cancer Institute and Behringwerke Aktiengesellschaft. His experience in these institutions has allowed him to contribute to significant advancements in cancer research and biotechnology.
Collaborations
Fleckenstein has collaborated with esteemed colleagues, including Marie-Christine Dokhelar and William A. Haseltine. These partnerships have further enriched his research and innovation efforts.
Conclusion
Bernard Fleckenstein's contributions to the field of biotechnology, particularly through his patent for the H. saimiri-HTLV-X region vector, highlight his role as an innovator in cell line development. His work continues to influence research and therapeutic strategies in the life sciences.